Geron Announces Conference Call to Discuss Third Quarter 2013 Financial Results
01 November 2013 - 9:00PM
Menlo Park, Calif., November 1,
2013 - Geron Corporation (Nasdaq: GERN) will announce its
financial results for the third quarter ended September 30, 2013,
on Thursday, November 7, 2013, after the market close. Geron's
management will also host a conference call for analysts and
investors on Thursday, November 7, 2013, at 4:30 p.m. Eastern Time
to discuss the company's third quarter results and recent
events.
Participants can access the conference call live
via telephone by dialing 877-303-9139 (U.S.); 760-536-5195
(international). The passcode is 95357406. If accessing the
conference call by telephone, please dial in at least 10 minutes
early to minimize any delay in joining the call. A live audio-only
webcast is also available at
http://edge.media-server.com/m/p/a6skpm7i/lan/en. The audio webcast
of the conference call will be available for replay approximately
one hour following the live broadcast through December 8, 2013.
About Geron
Geron is a clinical stage biopharmaceutical
company developing a first-in-class telomerase inhibitor,
imetelstat, in hematologic myeloid malignancies. For more
information about Geron, visit www.geron.com.
CONTACT:
Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com
###
This
announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the
information contained therein.
Source: Geron Corp. via Thomson Reuters ONE
HUG#1739908
Geron (NASDAQ:GERN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024
